Annual Total Liabilities
$15.96 M
-$10.05 M-38.63%
31 December 2023
Summary:
Mereo BioPharma annual total liabilities is currently $15.96 million, with the most recent change of -$10.05 million (-38.63%) on 31 December 2023. During the last 3 years, it has fallen by -$90.23 million (-84.97%). MREO annual total liabilities is now -84.97% below its all-time high of $106.19 million, reached on 31 December 2020.MREO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$16.21 M
-$1.27 M-7.26%
30 September 2024
Summary:
Mereo BioPharma quarterly total liabilities is currently $16.21 million, with the most recent change of -$1.27 million (-7.26%) on 30 September 2024. MREO quarterly total liabilities is now -84.73% below its all-time high of $106.19 million, reached on 31 December 2020.MREO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.6% | - |
| 3 y3 years | -85.0% | -81.8% |
| 5 y5 years | -63.5% | -73.4% |
MREO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -85.0% | at low | -81.8% | +23.8% |
| 5 y | 5 years | -85.0% | at low | -84.7% | +23.8% |
| alltime | all time | -85.0% | +161.6% | -84.7% | +165.7% |
Mereo BioPharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.21 M(-7.3%) |
| June 2024 | - | $17.48 M(+33.4%) |
| Mar 2024 | - | $13.10 M(-17.9%) |
| Dec 2023 | $15.96 M(-38.6%) | $15.96 M(-44.7%) |
| June 2023 | - | $28.88 M(+11.0%) |
| Dec 2022 | $26.01 M(-49.8%) | $26.01 M(-44.2%) |
| June 2022 | - | $46.64 M(-10.0%) |
| Dec 2021 | $51.85 M(-51.2%) | $51.85 M(-41.7%) |
| June 2021 | - | $88.90 M(-16.3%) |
| Dec 2020 | $106.19 M | $106.19 M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $105.29 M(+73.8%) |
| Dec 2019 | $60.57 M(+38.3%) | $60.57 M(-0.7%) |
| June 2019 | - | $60.97 M(+39.3%) |
| Dec 2018 | $43.78 M(-4.3%) | $43.78 M(-4.1%) |
| June 2018 | - | $45.67 M(-0.2%) |
| Dec 2017 | $45.75 M(+393.9%) | $45.75 M(+124.1%) |
| June 2017 | - | $20.41 M(+120.4%) |
| Dec 2016 | $9.26 M(+51.8%) | $9.26 M(-29.7%) |
| June 2016 | - | $13.18 M(+116.0%) |
| Dec 2015 | $6.10 M | $6.10 M |
FAQ
- What is Mereo BioPharma annual total liabilities?
- What is the all time high annual total liabilities for Mereo BioPharma?
- What is Mereo BioPharma annual total liabilities year-on-year change?
- What is Mereo BioPharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Mereo BioPharma?
What is Mereo BioPharma annual total liabilities?
The current annual total liabilities of MREO is $15.96 M
What is the all time high annual total liabilities for Mereo BioPharma?
Mereo BioPharma all-time high annual total liabilities is $106.19 M
What is Mereo BioPharma annual total liabilities year-on-year change?
Over the past year, MREO annual total liabilities has changed by -$10.05 M (-38.63%)
What is Mereo BioPharma quarterly total liabilities?
The current quarterly total liabilities of MREO is $16.21 M
What is the all time high quarterly total liabilities for Mereo BioPharma?
Mereo BioPharma all-time high quarterly total liabilities is $106.19 M